Pharmaceutical Price Regulation Scheme

We are conducting a market study of the pharmaceutical price regulation scheme.

Back to top

Introduction

We welcome the Government's response to the Pharmaceutical Price Regulation Scheme (PPRS) (pdf 335 kb) market study and in particular its acceptance of many of the principles that we believe should guide the design of a drug pricing scheme as set out in our report.  We recognise and welcome the fact that progress has been made in reforming the PPRS to incorporate elements of the value based pricing system that we proposed. 

We believe that more fundamental changes to future schemes will be necessary to bring about the benefits to patients, the NHS and the pharmaceutical industry that we highlighted in our report, but agree that the new scheme is a significant step forward.

Back to top

Further information

Our completed market study on the PPRS recommended that the current scheme should be reformed, to deliver better value for money from NHS drug spend and to focus business investment on drugs that have the greatest benefits for patients.

For more details, view our market study on the Pharmaceutical Price Regulation Scheme.

Back to: Goods